Friday, May 07, 2010
KY Gets Cystic Fibrosis Settlement Funds
KENTUCKY...
Kentucky's Medicaid program will receive more than $135,000 in a settlement with the manufacturer of a cystic fibrosis drug. Attorney General Jack Conway announced that Kentucky was part of a $75.2 million settlement with Novartis Pharmaceuticals Corp.
The settlement with the Switzerland-based company resolves claims that Novartis had knowingly promoted the sale and use of tobramycin for uses not approved by the U.S. Food & Drug Administration. entucky will receive more than $470,000, which is double the amount the state's Medicaid program spent on prescriptions written as a result of the company's off-label marketing. After reimbursing the federal government for its contribution, the Kentucky Medicaid program will retain $136,199.
Kentucky's Medicaid program will receive more than $135,000 in a settlement with the manufacturer of a cystic fibrosis drug. Attorney General Jack Conway announced that Kentucky was part of a $75.2 million settlement with Novartis Pharmaceuticals Corp.
The settlement with the Switzerland-based company resolves claims that Novartis had knowingly promoted the sale and use of tobramycin for uses not approved by the U.S. Food & Drug Administration. entucky will receive more than $470,000, which is double the amount the state's Medicaid program spent on prescriptions written as a result of the company's off-label marketing. After reimbursing the federal government for its contribution, the Kentucky Medicaid program will retain $136,199.
# posted by Homer Owens @ 9:05 AM 
